Effect of myrtle fruit syrup on abnormal uterine bleeding: a randomized double-blind, placebo-controlled pilot study

Marzieh Qaraaty, Seyed Hamid Kamali, Fataneh Hashem Dabaghian, Nafiseh Zafarghandi, Roshanak Mokaberinejad, Masumeh Mobli, Gholamreza Amin, Mohsen Naseri, Mohammad Kamalinejad, Mohsen Amin, Azizeh Ghaseminejad, Seyedeh Jihan HosseiniKhabiri, Daryush Talei, Marzieh Qaraaty, Seyed Hamid Kamali, Fataneh Hashem Dabaghian, Nafiseh Zafarghandi, Roshanak Mokaberinejad, Masumeh Mobli, Gholamreza Amin, Mohsen Naseri, Mohammad Kamalinejad, Mohsen Amin, Azizeh Ghaseminejad, Seyedeh Jihan HosseiniKhabiri, Daryush Talei

Abstract

Background: Myrtle (Myrtus communis L.) has been used in the Iranian Traditional Medicine as a treatment for abnormal uterine bleeding-menometrorrhagia. The main aim of this study is to evaluate the effect of myrtle fruit syrup on abnormal uterine bleeding-menometrorrhagia.

Methods: A randomized, double-blind, placebo-controlled pilot study was conducted on 30 women suffering from abnormal uterine bleeding-menometrorrhagia. Treatment comprised of giving 15 ml oral myrtle syrup daily (5 ml three times a day) for 7 days starting from the onset of bleeding. The myrtle syrup along with placebo was repeated for 3 consecutive menstrual periods. Menstrual duration and number of used pads were recorded by the Pictorial Blood loss Assessment Chart at the end of each menstrual period. The quality of life was also evaluated using the menorrhagia questionnaire.

Results: The mean number of bleeding days significantly declined from 10.6 ± 2.7 days to 8.2 ± 1.9 days after 3 months treatment with the syrup (p = 0.01) and consequently the participants in the intervention group used fewer pads after 3 months (16.4 ± 10.7) compared with the number of pads used at the beginning of the treatment (22.7 ± 12.0, p = 0.01). Bleeding days and number of pads used by the participants in the placebo group did not change significantly. Also significant changes of quality of life scores were observed in the intervention group after 3 months compared to the baseline.

Conclusion: Myrtle syrup is introduced as a potential remedy for abnormal uterine bleeding-menometrorrhagia.

Figures

Figure 1
Figure 1
Study flow chart.

References

    1. Gibbs R, Karlan B, Haney A, Nygaard I. Danforth’s obstetrics and gynecology. 10. Philadelphia: Lippincott Williams & Wilkins; 2008. pp. 664–671.
    1. Livingstone M, Fraser IS. Mechanisms of abnormal uterine bleeding. Hum Reprod Update. 2002;8(1):60–67.
    1. Marret H, Fauconnier A, Chabbert-Buffet N, Cravello L, Golfier F, Gondry J, Agostini A, Bazot M, Brailly-Tabard S, Brun JL. Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause. Eur J Obstet Gynecol Reprod Biol. 2010;152(2):133–137.
    1. Critchley HO, Maybin JA. Molecular and cellular causes of abnormal uterine bleeding of endometrial origin. Semin Reprod Med; Thieme Med Pub. 2011;29(5):400–409. doi: 10.1055/s-0031-1287664.
    1. Shobeiri S, Sharei S, Heidari A, Kianbakht S. Portulaca oleracea L. in the treatment of patients with abnormal uterine bleeding: a pilot clinical trial. Phytother Res. 2009;23(10):1411–1414.
    1. Telner DE, Jakubovicz D. Approach to diagnosis and management of abnormal uterine bleeding. Can Fam Physician. 2007;53(1):58–64.
    1. Fathima A, Sultana A. Clinical efficacy of a Unani formulation ‘Safoof Habis’ in menorrhagia:A randomized controlled trial. Eur J Integr Med. 2012;4(3):e315–e322.
    1. Speroff l, Glass R, Kase N. Clinical gynecology endocrinology and infertility. 8th. Philadelphia, USA: lippincott williams and wilkins; 2011. pp. 592–617.
    1. Bereak SJ. Break and Novaks Gynecology. 15. Philadelphia, USA: lippincott williams and wilkins; 2012. pp. 403–409.
    1. JANET RA, Sharon K, Robert M. Abnormal uterine bleeding. Am Fam Physician. 2004;69(8):1915–1926.
    1. Leminen H, Hurskainen R. Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety. Int J Womens Health. 2012;4:413–421.
    1. Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J. the ESTHER study. Hormone therapy and venous thromboembolism among postmenopausal women impact of the route of estrogen administration and progestogens. Circulation. 2007;115(7):840–845.
    1. Muoukhah S, Mazari Z, Ghoshtasbi A, Moayed Mohseni S. The effect of tranexamic acid on the quality of life and blood loss of woman with menorrhagia: A clinical trial. Arak Med Uni J. 2012;15(3):75–84.
    1. Zafarghandi N, Torkestani F, Hadavand S, Zaeri F, Jalilinejad H. Evaluation of libido in post hystrectomy patients. Tehran Uni Med J. 2006;64(11):77–80.
    1. Jensen JT, Parke S, Mellinger U, Machlitt A, Fraser IS. Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial. Obstet Gynecol. 2011;117(4):777–787.
    1. Jorjani SE. Al- Aghraz al- Tibbia val Mabohess al- Alaiia. Iran, Tehran: Tehran university press; 2005. pp. 761–764.
    1. Zafarghandi N, Jafari F, Moradi F, Alizade F, Karimi M, Alizade M. A study on the frequency of signs and symptoms of dystemperament in hypermenorrhea from viewpoint of Traditional Iranian Medicine. IJOGI. 2012;15(24):8–16.
    1. Ibn-e-sina AH. Al-Qanun fit-tib [The Canon of Medicine] Beirut, Lebanon: Alaalami Beirut library Press (research of shamsedine); 2005. pp. 442–443.
    1. Aqili khorasani SMHIMH. Moalejate Aqili (medicine) Iran, Qom: Jalaleddin; 2008. pp. 771–773.
    1. Arzani MA. Tebbe Akbari 2. 1. Iran, Qom: Jalaleddin; 2008. pp. 961–964.
    1. Mozaffarian V. Trees and Shrubs of Iran. 1. Tehran: Farhang Moaser Publishers; 2005. p. 357.
    1. Amin G. Popular Medicinal plants of Iran. 2. Tehran: Vice- chancellorship of Research, Tehran University of Medical sciences; 2005. p. 254.
    1. Fleming T. PDR for herbal medicine. 4. Montvale: THomson; 2007. pp. 596–597.
    1. Zanetti S, Cannas S, Molicotti P, Bua A, Cubeddu M, Porcedda S, Marongiu B, Sechi LA. Evaluation of the Antimicrobial Properties of the Essential Oil of Myrtus communis L. against Clinical Strains of Mycobacterium spp. Interdiscip Perspect Infect Dis. 2010. doi: 10.1155/2010/931530.
    1. Jorsaraei SG, Moghadamnia AA, Firoozjahi AR, Miri SM, Omranirad A, Saghebi R, Hashemi SF. A comparison on histopathological effects on Myrtle extract and silver sulfadiazine 1% on healing of second degree burn wound in rats. J Qazvin Univ Med Sci. 2006;10(1):6–15.
    1. Sumbul S, Ahmad MA, Asif M, Saud I, Akhtar M. Evaluation of Myrtus communis Linn. berries (common myrtle) in experimental ulcer models in rats. Hum Exp Toxicol. 2010;29(11):935–944.
    1. Zaidi SF, Muhammad JS, Shahryar S, Usmanghani K, Gilani A, Jafri W, Sugiyama T. Anti-inflammatory and cytoprotective effects of selected Pakistani medicinal plants in Helicobacter pylori-infected gastric epithelial cells. J Ethnopharmacol. 2012;141(1):403–410.
    1. Serce S, Ercisli S, Sengul M, Gunduz K, Orhan E. Antioxidant activities and fatty acid composition of wild grown myrtle (Myrtus communis L.) fruits. Pharmacogn Mag. 2010;6(21):9.
    1. Ghayeni M. Salehi Garabadin. Tehran: Islamic medicine and complementary medicine institute press; 2004. p. 156.
    1. Aghili M. Kabir Garabadin. Tehran: Islamic medicine and complementary medicine institute press; 2004. pp. 571–576.
    1. Mazari Z, Ghoshtasbi A, Muoukhah S, Saki F. Translation of Iranian version of Menorrhagia questionaire. Payesh. 2011;11(1):83–88.
    1. Ruta D, Garratt A, Chadha Y, Flett G, Hall M, Russell I. Assessment of patients with menorrhagia: how valid is a structured clinical history as a measure of health status? Qual Life Res. 1995;4(1):33–40.
    1. Wyatt KM, Dimmock PW, Walker TJ, O’Brien P. Determination of total menstrual blood loss. Fertil Steril. 2001;76(1):125–131.
    1. Tuberoso CIG, Rosa A, Bifulco E, Melis MP, Atzeri A, Pirisi FM, Dessì MA. Chemical composition and antioxidant activities of Myrtus communis L. berries extracts. Food Chem. 2010;123(4):1242–1251.
    1. Evans WC. Trease and evans pharmacognosy. United Kingdom: Saunders; 2009. p. 228.
    1. Wang H, Nair MG, Strasburg GM, Chang Y-C, Booren AM, Gray JI, DeWitt DL. Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries. J Nat Prod. 1999;62(2):294–296.
    1. Gonzalez-Gallego J, Sánchez-Campos S, Tunon M. Anti-inflammatory properties of dietary flavonoids. Nutr Hosp. 2007;22(3):287–293.
    1. Mukherjeea GG, Gajarajb AJ, Mathiasc J, Marya D. Treatment of abnormal uterine bleeding with micronized flavonoids. Int J Gynecol Obstet. 2005;89(2):156–157.
    1. Koeberle A, Pollastro F, Northoff H, Werz O. Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E2 synthase 1. Br J Pharmacol. 2009;156(6):952–961.
    1. Mokaberinejad R, Zafarghandi N, Bioos S, Dabaghian FH, Naseri M, Kamalinejad M, Amin G, Ghobadi A, Tansaz M, Akhbari A. Mentha longifolia syrup in secondary amenorrhea: a double-blind, placebo-controlled, randomized trials. DARU J Pharm Sci. 2012;20(1):1–8.
    1. Kamali SH, Khalaj AR, Hasani-Ranjbar S, Esfehani MM, Kamalinejad M, Omidmalayeri S, Kamali SA. Efficacy of ‘Itrifal Saghir’, a combination of three medicinal plants in the treatment of obesity; A randomized controlled trial. DARU J Pharm Sci. 2012;20:33.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi